Company to host Investor Webcast on Thursday, June 26, 2025, at 8:30 am E.T.

Percheron Therapeutics obtains exclusive worldwide rights to Hummingbird Bioscience’s anti-VISTA mAb for further clinical development ; Hummingbird Bioscience stands to receive ...

As COVID testing contracts expand globally, Dr. Anosh Ahmed remains focused on restoring confidence in public health ...

With the launch of its legal Dianabol pills in the United States, DBal Max is delivering on the promise of real ...

Dr. Anosh Ahmed expands U.S. and international COVID testing contracts with focus on compliance, fraud prevention, and ...

With the US launch of its legal steroid alternatives, CrazyBulk is setting a new standard for muscle-building nutrition.

“We’ve always believed in the power of mental rehearsal and neural retraining,” said Lisa Wimberger, founder of the Neurosculpting® Institute. “This study is an exciting confirmation that our specific ...

Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, today announced that the company will release ...

REYKJAVÍK, Iceland and LUXEMBOURG, June 25, 2025 (GLOBE NEWSWIRE) -- The 2025 Annual and Extraordinary General Meeting (the "2025 AGM") of Alvotech (the "Company") was held on June 25, 2025, at Arendt ...

DBV Technologies Announces First Subject Screened in COMFORT Toddlers Supplemental Safety Study in Peanut Allergic Toddlers 1 – 3 Years Old First subject screened at the Respiratory Medicine Research ...

The winning artwork will be proudly displayed in HNL Lab Medicine Patient Service Centers across the region, bringing color, inspiration, and a sense of community to patient rooms.

Clinical Pipeline Update: The Company’s lead candidates—LP-310 for oral lichen planus and LP-10 for hemorrhagic cystitis—continue to show promising clinical progress. Final topline data from the Phase ...